Citation Impact
Citing Papers
Intersexuality and Gender Identity Differentiation
1999
A prospective study of the prevalence of clear‐cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia
1994
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Transgender people: health at the margins of society
2016 Standout
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Relaxin is a potent renal vasodilator in conscious rats
1999
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
1993
Regional gray matter variation in male-to-female transsexualism
2009
Vascular Matrix Metalloproteinase-9 Mediates the Inhibition of Myogenic Reactivity in Small Arteries Isolated from Rats after Short-Term Administration of Relaxin
2006 Standout
Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.
1995
STEROID RESPONSES TO ACTH IN WOMEN WITH POLYCYSTIC OVARIES
1989
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Steroid 5α-Reductase 2 Deficiency*
1993
Polycystic Ovary Syndrome
1995 Standout
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
2005 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Medical Therapy of Cushing's Disease
2002
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Consensus Statement on Management of Intersex Disorders
2006 Standout
Response to Androgen Treatment in a Patient with Partial Androgen Insensitivity and a Mutation in the Deoxyribonucleic Acid-Binding Domain of the Androgen Receptor1
1998
Cushing's syndrome
2006 Standout
Polycystic ovary syndrome
2016 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Hormonal Treatment of Postmenopausal Women
1994
Steroid 5α-reductase 2 deficiency
2016
Gender Change in 46,XY Persons with 5α-Reductase-2 Deficiency and 17β-Hydroxysteroid Dehydrogenase-3 Deficiency
2005
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Late-Onset 21-Hydroxylase Deficiency Mimicking Idiopathic Hirsutism or Polycystic Ovarian Disease
1982
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Late-Onset Adrenal Steroid 3β-Hydroxysteroid Dehydrogenase Deficiency. I. A Cause of Hirsutism in Pubertal and Postpubertal Women*
1985
Identification of heterozygotic carriers of 21-hydroxylase deficiency: Sensitivity of ACTH stimulation tests
1998
III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia
2001 Standout
Male Pseudohermaphroditism Due to 5α-Reductase 2 Deficiency: Outcome of a Brazilian Cohort
2003
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Pharmacokinetics, Efficacy, and Safety of a Permeation-Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men*
1999 Standout
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
Controls of Hair Follicle Cycling
2001 Standout
Cushing's syndrome
1985
Hormonal Therapy of Male Hypogonadism
1994
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
The Incidence of Late-Onset Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency among Hirsute Women*
1984
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Inherited 5α-reductase deficiency in man
1986
The Role of Androgens in Male Gender Role Behavior
1999
Measurement of catecholamines and their metabolites
2004
Non‐competitive steroid inhibition of oestrogen receptor functions
2002
Mechanisms of Renal Vasodilation and Hyperfiltration During Pregnancy
2004
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Works of D. E. BU'LOCK being referenced
HORMONAL CHANGES IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER TREATED WITH TRILOSTANE AND DEXAMETHASONE
1985
The effect of pseudopregnancy on glomerular filtration rate and salt and water reabsorption in the rat.
1982
ADRENAL STEROIDOGENESIS IN HETEROZYGOTES FOR 21‐HYDROXYLASE DEFICIENCY
1979
Reference Ranges for Free Catecholamine/Creatinine Ratios in Random Urines from Normal Children Aged 5 to 16 Years
1991
ADRENAL PROGESTERONE, 17α‐HYDROXYPROGESTERONE AND CORTISOL RESPONSES TO SYNACTHEN IN NORMAL WOMEN AND WOMEN WITH VARIOUS GYNAECOLOGICAL DISORDERS
1983
High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.
1984
Study of the effect of estradiol on gonadotrophin levels in untreated male-to-female transsexuals
1985
Trilostane in the treatment of advanced breast cancer
1983
ADRENAL STEROIDOGENESIS IN HIRSUTE WOMEN
1980
EXPERIENCE WITH TRILOSTANE IN THE TREATMENT OF CUSHING'S SYNDROME
1983
Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women
1987